Acadia Pharmaceuticals buy Royal Bank of Canada
Start price
28.02.24
/
50%
€22.00
Target price
28.02.25
€32.29
Performance (%)
-36.16%
Price
27.09.24
€14.05
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals is performing very badly with a performance of -36.16%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Royal Bank of Canada from $36.00 to $35.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€13.87
07.08.24
07.08.24
€23.79
07.08.25
07.08.25
1.30%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.79
25.06.24
25.06.24
€27.09
25.06.25
25.06.25
-5.04%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.60
03.11.23
03.11.23
€30.73
03.11.24
03.11.24
-37.85%
27.09.24
27.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€29.00
14.07.23
14.07.23
€29.37
14.07.24
14.07.24
-44.09%
15.07.24
15.07.24